Ovid Therapeutics Inc. OVID
Set alert
2.44 USD +0.05 +2.14%
As of Nov 3, 10:52 AM ET
2.39 Day range 2.50
1.18 52-week range 3.11
- YTD
- +49.76%
- 1 year
- +76.89%
- Open
- 2.39
- Prev close
- 2.39
- Mkt cap
- 476.74M
- Vol
- 229.59K
- Avg vol
- 1.71M
- EPS
- -0.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.39
- High
- 2.50
- Forward P/E
- -2.44
- Beta
- 0.41
- Short ratio
- 3.05
- Inst. own
- 56.41%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.14
- 200-d avg
- 1.76
- 1y target
- 3.26
Analyst view
Consensus: buy
Buy
Price target (mean) 3.26 +33.5% upside
Now 2.44
- Target (low)
- 1.30
- Target (mean)
- 3.26
- Target (high)
- 5.00
Ratings (0m) 8 6 buy · 2 hold · 0 sell
- Strong buy1
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.16945 | -0.18834 – -0.15 | -0.22 | +23.0% | 187.50K | +32.5% | 3 |
| Next quarter | -0.16 | -0.16 – -0.16 | -0.17 | +5.9% | 100.00K | -32.4% | 1 |
| Current year | -0.41041 | -0.43124 – -0.39 | -0.74 | +44.5% | 658.12K | +68.0% | 3 |
| Next year | -0.68089 | -0.72266 – -0.63 | -0.41041 | -65.9% | 4.62M | +601.6% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 18, 2024 | BTIG | Maintained | Buy | Buy |
| Jun 18, 2024 | B. Riley Securities | Maintained | Buy | Buy |
| Jun 18, 2024 | Citigroup | Maintained | Neutral | Neutral |
| Jun 18, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 7, 2024 | Citigroup | Maintained | Neutral | Neutral |
| Apr 30, 2024 | B. Riley Securities | Initiated | — | Buy |
| Apr 29, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 5, 2024 | Wedbush | Initiated | — | Outperform |
| Dec 21, 2023 | BTIG | Initiated | — | Buy |
| Jun 14, 2023 | JonesTrading | Initiated | — | Buy |
| May 2, 2023 | Ladenburg Thalmann | Reiterated | — | Buy |
| Aug 29, 2022 | Citigroup | Maintained | — | Neutral |
| May 20, 2022 | Citigroup | Maintained | — | Neutral |
| Aug 25, 2021 | Citigroup | Maintained | — | Neutral |
| Apr 20, 2021 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Dec 2, 2020 | Citigroup | Downgrade | Buy | Neutral |
| Dec 2, 2020 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Aug 26, 2020 | Citigroup | Maintained | — | Buy |
| Jun 18, 2020 | Cantor Fitzgerald | Maintained | — | Overweight |
| Sep 24, 2019 | Citigroup | Maintained | — | Buy |
| Sep 24, 2019 | Citigroup | Maintained | — | Buy |
| Sep 4, 2019 | RBC Capital | Initiated | — | Outperform |
| Nov 15, 2018 | Cantor Fitzgerald | Initiated | — | Overweight |
| Apr 20, 2018 | Ladenburg Thalmann | Initiated | — | Buy |